Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease

NCT00404131 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: diquafosol tetrasodium (INS365) Ophthalmic Solution

Sponsor

Merck Sharp & Dohme LLC